Evidence map›Paper›PMID 36423026›Full record

ArticleVaccines2022

Long-Term CD4

Corey Gallen, Christopher W Dukes, Amy Aldrich, Lauren Macaisa, Qianxing Mo, Christopher L Cubitt, Shari Pilon-Thomas, Anna R Giuliano, Brian J Czerniecki, Ricardo L B Costa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Corey GallenDepartment of Clinical Science, Moffitt Cancer Center, Tampa, FL 33612, USA.
Christopher W DukesDepartment of Immunology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Amy AldrichDepartment of Clinical Science, Moffitt Cancer Center, Tampa, FL 33612, USA.
Lauren MacaisaDepartment of Clinical Science, Moffitt Cancer Center, Tampa, FL 33612, USA.
Qianxing MoDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0002-0021-7694
Christopher L CubittImmune Monitoring Core Facility, Moffitt Cancer Center, Tampa, FL 33612, USA.
Shari Pilon-ThomasDepartment of Immunology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Anna R GiulianoCenter for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL 33612, USA.
Brian J CzernieckiDepartment of Clinical Science, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0003-4519-9570
Ricardo L B CostaDepartment of Breast Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0002-3303-3234

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

We conducted a prospective study to evaluate immune responses to SARS-CoV-2 in oncology workers in which we collected blood and clinical data every 6 months. Spike-specific CD4

Indexed as

COVID-19deltaimmunityomicrononcology workersSARS-CoV-2vaccine

Identifiers

PMID36423026
PMCPMC9696551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.